The diagnostic use of procalcitonin for bacterial infections remains a matter of debate. Most
studies have used ambiguous outcome measures such as sepsis instead of infection. We …

Inflammation is a key player in the development of an increasing amount of diseases. The
soluble urokinase plasminogen activator receptor (suPAR) is a highly flexible molecule with …

Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models
similar to primary FSGS, and one recent study demonstrated elevated levels of serum …

Purpose The soluble form of the urokinase-type plasminogen activator receptor (suPAR)
and proadrenomedullin (proADM) are two new and promising sepsis biomarkers. We …

Introduction Severe acute pancreatitis (AP) is associated with high morbidity and mortality.
Early prediction of severe AP is needed to improve patient outcomes. The aim of the present …

Background: Soluble urokinase-type plasminogen activator receptor (suPAR) has the
potential to diagnose infectious diseases. Due to the lack of reliable biomarkers and the …

Background Recently, serum soluble urokinase receptor (suPAR) has been proposed as a
cause of two thirds of cases of focal segmental glomerulosclerosis (FSGS). It was noted to …

OBJECTIVES: Soluble urokinase plasminogen activator receptor (suPAR) serum
concentrations have recently been described to reflect the severity status of systemic …

The serum concentration of soluble urokinase-type plasminogen activator receptor (suPAR)
reflects immune activation. We performed a meta-analysis to evaluate the usefulness of …

Elevated serum-soluble urokinase receptor (suPAR) levels have been described in patients
with focal segmental glomerulosclerosis (FSGS) in several different cohorts. However, it …